FDA Drug Application (022104) for VENLAFAXINE HYDROCHLORIDE by OSMOTICA PHARM

Back to FDA Applications sponsored by OSMOTICA PHARM

Application Number022104
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
DosageEQ 37.5MG BASE
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameVENLAFAXINE HYDROCHLORIDE
Active IngredientVENLAFAXINE HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient VENLAFAXINE HYDROCHLORIDE3


Back to FDA Applications sponsored by OSMOTICA PHARM